Chemotherapy Discussion Questions
Before undergoing chemotherapy treatment, it is smart to ask your doctor any and all questions you have. Do not be afraid to ask questions and expect answers. After all, it's your health. Some questions you may want answered are:
- What is the name of my chemotherapy regimen?
- What drugs are used?
- How is treatment given? Intravenously, orally, or topically (in a cream)?
- What is the goal of the treatment?
- Is the treatment given in cycles? If so, how long is each cycle and how many cycles will there be? If not, how is it given?
- What are the side effects of each drug?
- How should I prepare to handle these side effects?
- Are there any treatments to help with side effects?
- Which side effects should I report to you immediately?
- Will some side effects require immediate treatment?
- How can I tell if the drugs are working?
- What tests will be done and how often?
- Are there any dietary restrictions while I’m on chemotherapy? Any other restrictions?
- Do I need a mediport or other permanent IV?
- Is there any other information that may be important?
You can also ask about the survival rate of patients on you chemotherapy regimen, but statistics are not always helpful in determining outcome. Stay positive and realize that, no matter the statistics, your case is unique.
Lymphoma Support Groups
SupportGroups.com builds awareness and support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
